Abstract:Abstract BACKGROUND: Epithelial-mesenchymal transition (EMT) is known to play an important role in breast cancer invasion and metastatic progression and to be associated with cancer stem cells and basal-like subtype. However, its role in the progression of in situ to invasive breast carcinoma is uncertain. To investigate this question, we evaluated the difference in the expression of EMT-related markers between pure ductal carcinoma in situ (DCIS) and invasive carcinomas according to molecular subtype. METHODS: We performed immunohistochemical analyses of EMT-related markers [expression of vimentin, smooth muscle actin (SMA), osteonectin and N-cadherin, translocation of β-catenin and loss of E-cadherin] and breast cancer stem cell markers (CD44+/CD24−, ALDH1) in 320 invasive carcinomas and 179 pure DCIS of breast using tissue microarrays. We also analyzed 39 basal-like invasive cancers with adjacent DCIS component to determine the difference in the expression of EMT-related markers in the invasive and DICS component within individual cases. RESULTS: In invasive carcinomas, vimentin, SMA and osteonectin were highly expressed in basal-like subtype. In addition, loss of E-cadherin and translocation of β-catenin were most frequently found in basal-like subtype. Furthermore, there were positive correlations between the expression of EMT-related markers and stem cell markers (CD44+/CD24- and ALDH1). However, there was no significant difference in the expression of EMT-related markers according to molecular subtype in pure DCIS. When comparing invasive carcinoma with pure DCIS, expression of EMT-related markers was significantly higher in invasive carcinoma than in pure DCIS. Subgroup analysis revealed higher expression of EMT-related markers in invasive carcinoma than in DCIS in basal-like subtype, but not in non-basal-like subtypes. Moreover, in 39 basal-like invasive cancers with adjacent DCIS, expression of mesenchymal markers was increased in invasive component compared to DCIS component. CONCLUSIONS: Our study confirmed that EMT is an intrinsic characteristic of basal-like subtype and is associated with breast cancer with stem cell phenotype. However, increased expression of EMT-related markers in invasive carcinoma compared to pure DCIS, especially in basal-like subtype, and in the invasive component of basal-like invasive carcinoma with DCIS component also suggests a role of EMT in the transition of in situ- to invasive carcinoma in basal-like breast cancer. Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P5-04-03.

[Expression and Clinical Significance of Moesin and E-cadherin in Invasive Carcinoma of Breast, No Specific Type].

Abstract P5-04-03: Epithelial-mesenchymal Transition is Associated with in Situ to Invasive Transition of Basal-Like Breast Cancer

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]

[E-Cadherin Associated Protein Expression and Its Significance in Invasive Lobular Carcinoma and Invasive Ductal Carcinoma of Breast].

[Expression and Clinical Significance of Beclin1 and PTEN in Endometrial Carcinoma].

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

Expressions of COX-2,E-cad Gene and Protein in Invasive Ductal Carcinoma and the Clinical Significance

Expression of Cell Adhesion Molecules, Estrogen Receptor, and Progesterone Receptor and Their Significance in Invasive Ductal Carcinoma and Invasive Lobular Carcinoma of Breast

Significance and Expression of E-cadherin, Β-Catenin and PTEN in Cervical Squamous Cell Carcinoma and Cervical Intraepithelial Neoplasia Tissues

The expression and clinical significance of CIP2A and c-Myc in breast cancer

Expressions and clinical significance of CCN5 and E-cadherin in primary and recurrent lesions of breast cancer

Expression of E-cadherin, Beta-Catenin, Cathepsin D, Gelatinases and Their Inhibitors in Invasive Ductal Breast Carcinomas

Β-Catenin Expression:The Role in Carcinogenesis and Development of Human Breast Cancer

The expression and significance of E - cadherin and laminin in hydatidiform mole and invasive mole

Expressions of Snail and E-cadherin in epithelial carcinomas and their clinical significance

Expressions of biomarkers in breast ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) and their relationship with sonographic features

Expression of E-, P- and N-Cadherin and Its Clinical Significance in Cervical Squamous Cell Carcinoma and Precancerous Lesions

Expressions and the clinical significances of KAI1 and E-cadherin in breast invasive lobular carcinoma

Expression of Ezrin and its relationship with clinicopathological characteristics in breast cancer

Relationship Between Expression of Cell Adhesion Molecules and the Metastatic Mechanism in Invasive Micropapillary Carcinoma of the Breast

Expression and Clinical Significance of Eps8, E-cadherin and Vimentin in Cervical Squa-Mous Cell Carcinoma